Zohar 2011b.

Trial name or title	Randomized placebo‐controlled trial of hydrocortisone in PTSD prophylaxis
Methods	Study type: interventional Allocation: randomised Endpoint classification: efficacy study Intervention model: parallel assignment Masking: double‐blind (subject, caregiver, investigator, outcomes assessor) Primary purpose: prevention
Participants	Ages eligible for study: no information provided Genders eligible for study: no information provided Inclusion criteria: no information provided
Interventions	Pharmacological intervention: single injection of 90 to 140 mg (proportioned to body weight) of hydrocortisone
Outcomes	Primary outcome measures: no information provided Secondary outcome measures: no information provided
Starting date	August 2011
Contact information	Contact: Joseph Zohar, MD; jzohar@post.tau.ac.il Program Officer: Farris K. Tuma; ftuma@mail.nih.gov
Notes	—

CAPS: Clinician‐Administered PTSD Scale
 DSM‐IV: Diagnostic and Statistical Manual IV
 PTSD: post‐traumatic stress disorder